Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Influenza and Other Respiratory Viruses
|
April 5, 2013
Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents
Stephen B Lambert, Lai-man R Chuk, Michael D Nissen, et al.
The Lancet. Infectious Diseases
|
September 10, 2018
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Annelies Wilder-Smith, Joachim Hombach, Neil Ferguson, et al.
Open Forum Infectious Diseases
|
September 2, 2024
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
Joanne M Langley, Terry M Nolan, Mika Rämet, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Hareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
Ebiomedicine
|
November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Terry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
The New England Journal of Medicine
|
July 30, 2020
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Shabir A Madhi, Fernando P Polack, Pedro A Piedra, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Influenza and Other Respiratory Viruses
|
April 5, 2013
Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents
Stephen B Lambert, Lai-man R Chuk, Michael D Nissen, et al.
The Lancet. Infectious Diseases
|
September 10, 2018
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Annelies Wilder-Smith, Joachim Hombach, Neil Ferguson, et al.
Open Forum Infectious Diseases
|
September 2, 2024
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
Joanne M Langley, Terry M Nolan, Mika Rämet, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Hareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
Ebiomedicine
|
November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Terry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
The New England Journal of Medicine
|
July 30, 2020
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Shabir A Madhi, Fernando P Polack, Pedro A Piedra, et al.
Page
of 2